Home » Initial Results Released on Three-Way GMP Inspection Pilot
Initial Results Released on Three-Way GMP Inspection Pilot
October 14, 2010
Information on GMP inspections at more than 1,000 active pharmaceutical ingredient (API) manufacturing sites has been entered in a master list compiled by the U.S. Food and Drug Administration (FDA), the EU’s European Medicines Agency and European Directorate for the Quality of Medicines and Healthcare and Australia’s Therapeutic Goods Administration (TGA). Includes the full text of European Medicines Agency Interim Report Joint Inspection Pilot Program.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor